Drew serves as acting President of UsAgainstAlzheimer's and the Executive Director of The Global CEO Initiative on Alzheimer’s Disease, a coalition of leading corporations investing in Alzheimer’s disease research, treatment and care. He is also a Partner at High Lantern Group, a healthcare consultancy focused on the intersection of business strategy and public policy.